Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of oral and maxillofacial surgery

• Publication date

  2004-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JOMS.2004.02.004PMID 15122554
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bisphosphonate-induced osteopetrosis.

  2003cited by this paper
• Effects of alendronate on the removal torque of implants in rats with induced osteoporosis.

  2003cited by this paper
• Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer.

  2002cited by this paper
• American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma.

  2002cited by this paper
• Raloxifene, Estrogen, and Alendronate Affect the Processes of Fracture Repair Differently in Ovariectomized Rats

  2002cited by this paper
• Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic Acid

  2002cited by this paper
• Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.

  2002cited by this paper
• BisphosphonatesMechanisms of Action

  2002cited by this paper
• Pamidronate induces modifications of circulating angiogenetic factors in cancer patients.

  2001cited by this paper
• Effect of growth hormone and pamidronate on bone blood flow, bone mineral and IGF-I levels in the rat.

  2000cited by this paper
• Optimising treatment of bone metastases by Aredia(TM) and Zometa(TM).

  2000cited by this paper
• American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.

  2000cited by this paper
• Optimising treatment of bone metastases by Aredia™ and Zometa™

  2000cited by this paper
• Suppressed Bone Turnover by Bisphosphonates Increases Microdamage Accumulation and Reduces Some Biomechanical Properties in Dog Rib

  2000cited by this paper
• Effect of Bisphosphonate (Incadronate) on Fracture Healing of Long Bones in Rats

  1999cited by this paper
• Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group.

  1999cited by this paper
• Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group.

  1998cited by this paper
• Effect of pamidronate on bone blood flow in oophorectomized rats.

  1998cited by this paper
• Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.

  1998cited by this paper
• Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.

  1998cited by this paper
• Reduction in new metastases in breast cancer with adjuvant clodronate treatment.

  1998cited by this paper
• Bisphosphonates: mechanisms of action

  1998cited by this paper
• An In Vitro and In Vivo Study of Cytokines in the Acute-Phase Response Associated with Bisphosphonates

  1997cited by this paper
• Long‐Term Effects of Bisphosphonates on the Growing Skeleton: Studies of Young Patients with Severe Osteoporosis

  1997cited by this paper
• Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group.

  1996cited by this paper
• Bisphosphonates: mechanisms of action.

  1996cited by this paper
• Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group.

  1996cited by this paper
• A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders.

  1995cited by this paper
• Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

  1995cited by this paper
• Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis: a case report.

  1995cited by this paper
• Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone.

  1994cited by this paper
• Delayed progression of bone metastases with pamidronate therapy in breast cancer patients: a randomized, multicenter phase III trial.

  1994cited by this paper
• Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomas.

  1994cited by this paper
• Palliative pamidronate treatment in patients with bone metastases from breast cancer.

  1993cited by this paper
• Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.

  1993cited by this paper
• Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.

  1989cited by this paper

• Bone Healing After Tooth Extraction in a Patient on Oral Bisphosphonates: A Case Report

  2026cites this paper
• Asia-Pacific consensus statement on medication-related osteonecrosis of the jaw in patients with osteoporosis

  2026cites this paper
• Medication-related osteonecrosis of the jaw primary prevention: multidomain long-term intervention versus pre-bisphosphonate treatment standalone dental intervention. A retrospective multi-center comparative cohort study

  2026cites this paper
• Progress in Research on Medication‐Related Osteonecrosis of the Jaw: From Pathophysiological Mechanisms to Clinical Treatment

  2026cites this paper
• Treatment protocol for medication-related osteonecrosis of the jaws: stages I and II-based on a pharmacological and surgical scheme.

  2025cites this paper
• V-ATPase and Lysosomal Energy Sensing in Periodontitis and Medicine-Related Osteonecrosis of the Jaw

  2025cites this paper
• Effect of clindamycin on human osteoblasts treated with zoledronate: An in vitro study.

  2025cites this paper
• Ozone therapy for medication-related osteonecrosis of the jaw: a scoping review.

  2025cites this paper
• A case of stage 3 medication-related osteonecrosis of the jaw in remission with conservative therapy

  2025cites this paper
• Effectiveness of Pharmacists' Recommendations for Dental Examinations for Prevention of Medication-Related Osteonecrosis of the Jaw.

  2025cites this paper
• Mitochondrial Transplantation: A Paradigm Shift in Osteoporosis Therapy

  2025cites this paper
• Awareness and Attitudes Toward Medication‐Related Osteonecrosis of the Jaw Among Physicians: A Cross‐Sectional Study

  2025cites this paper
• Emerging Role of Enzyme-Immobilized Nanocarriers in Osteoporosis: Advances and Challenges

  2025cites this paper
• Zoledronate and Clodronate affecting bone repair in non-critical defects grafted with carbonated nanostructured hydroxyapatite: an in vivo study fostering clinical reasoning

  2025cites this paper
• The Microbiological Background of Medication-Related Osteonecrosis of the Jaw (MRONJ): Clinical Evidence Based on Traditional Culture and Molecular Biological Detection Methods

  2025cites this paper
• Vitamin D3 deficiency and MRONJ: insights from a Bi-Center Study in Argentina. A preliminary cross-sectional study

  2025cites this paper
• Use of Bisphosphonates and The Effect of Osteonecrosis of The Jaw – Review

  2025cites this paper
• Prevalence of Osteonecrosis of the Jaw (ONJ) in Patients Exposed to Bisphosphonates at a University Hospital in Marrakech

  2025cites this paper
• Radiologic and Pathologic Insights into Medication-Related Osteonecrosis of the Jaw in Myeloma Patients: A Report of 3 Cases

  2025cites this paper
• Bisphosphonate-induced posterior scleritis with sectorial choroidal thickening on optical coherence tomography without visible ocular findings.

  2025cites this paper
• ONJ (MRONJ) Update 2024: Osteonecrosis of the Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment—A National Italian Symposium

  2025cites this paper
• Monoclonal Antibodies and Osteonecrosis of the Jaw: A Systematic Review of Risk, Incidence, and Clinical Management in Dentistry

  2025cites this paper
• Classic Publications in the Field of Dentistry: A Bibliometric Analysis

  2025influential citation
• Drug-induced gingival diseases: insights from the FDA Adverse Event Reporting System (FAERS) database analysis.

  2025cites this paper
• Temporal evolution of publication bias in drug safety assessment: A case study on association between osteonecrosis of the jaw and bisphosphonates.

  2025cites this paper
• Two-year outcomes of denosumab treatment for osteoporosis comparing the effects of calcium and vitamin D supplementation

  2025cites this paper
• Prognostic indicators in medication-related osteonecrosis of the jaw: A systematic review and meta-analysis

  2025cites this paper
• Artificial intelligence for medication-related osteonecrosis of the jaw: a scoping review.

  2025cites this paper
• Orthodontics in Pediatric Osteoporosis: A Narrative Literature Review

  2025cites this paper
• Different effects of moderate tibial loading and Yoda1 on breast cancer-induced osteolysis in aged mice.

  2025cites this paper
• An evidence-guided review of preclinical strategies to counteract medication-related osteonecrosis of the jaw. What do rodent studies tell us?

  2025cites this paper
• A bibliometric analysis of the top 100 most-cited case reports and case series in dentistry

  2025cites this paper
• Osteoradionecrosis of the Jaw-Thinking Outside the Box, a Review of Emerging Treatment Paradigms.

  2025cites this paper
• The Incidence and Severity of Medication Related Osteonecrosis of the Jaws is Similar in Male and Female Mice.

  2024cites this paper
• Impaired Osteoclastogenesis in Medication-Related Osteonecrosis and Potential Clinical Management with BMP-2

  2024cites this paper
• Is There an Ideal Concentration of Ozonized Oil for the Prevention and Modulation of Zoledronate-Induced Mandibular Osteonecrosis? A Study on Senescent Rats

  2024cites this paper
• Disulfiram ameliorates bone loss in ovariectomized mice by suppressing osteoclastogenesis

  2024cites this paper
• A study of peri-implant tissue clinical parameters in patients starting anti-osteoporosis medication after existing implant function: a prospective cohort study

  2024cites this paper
• Clinical and radiologic treatment outcomes of implant presence tirggered-MRONJ: Systematic review of literature.

  2024cites this paper
• Osteoradionecrosis Rates Following Head and Neck Radiotherapy: Beyond the Numbers.

  2024cites this paper
• Improvement of Quality of Life after Surgical Treatment of Patients with MRONJ: A Prospective Analysis Using the SF-12 and OHIP-14 Questionnaires

  2024cites this paper
• Osteonecrosis of the Jaw Associated with Bisphosphonates Infusion for Treatment of Plasma Cell Myeloma—A Retrospective Observational Study of Northern Portuguese Population

  2024cites this paper
• Medications Affecting Treatment Outcomes in Dentistry: Part 2.

  2024cites this paper
• Concurrent Oral Squamous Cell Carcinoma and Bisphosphonate‐Related Osteonecrosis of the Maxilla: A Case Report and Literature Review

  2024cites this paper
• Considerations for oral and dental tissues in holistic care during long-haul space flights

  2024cites this paper
• Risk factors for medication-related osteonecrosis of the jaws in menopausal women

  2024cites this paper
• Prevention of bisphosphonate related osteonecroses of the jaw using autologous platelet concentrate

  2024cites this paper
• Serum albumin is a potential predictor of delayed healing after minor dental surgery among older patients aged over 65 years: A retrospective study

  2024cites this paper
• Volumetric analysis of spontaneous bone formation after segmental mandibulectomy in patients with MRONJ.

  2024cites this paper
• Mitigating aging and doxorubicin induced bone loss in mature mice via mechanobiology based treatments.

  2024cites this paper
• Bisphosphonate related osteonecrosis of the jaw: Known pathological entity or not?

  2024cites this paper
• Surgical and conservative treatment outcomes of medication-related osteonecrosis of the jaw located at tori: a retrospective study

  2024cites this paper
• A New Complexity Index in Implant Dentistry: Position Statement of the Implant Dentistry Study Consortium

  2024cites this paper
• Can medication-related osteonecrosis of the jaw be attributed to specific microorganisms through oral microbiota analyses? A preliminary study

  2024cites this paper
• Ozone therapy effect in medication-related osteonecrosis of the jaw as prevention or treatment: microtomographic, confocal laser microscopy and histomorphometric analysis

  2024cites this paper
• Effect of Antiresorptive Drugs on Osseointegrated Dental Implants: A Systematic Review

  2024cites this paper
• Similarities and Differences between Osteoclast-Mediated Functional Activation of NK, CD3+ T, and γδ T Cells from Humans, Humanized-BLT Mice, and WT Mice.

  2024cites this paper
• Limitations of immunodeficient mice as models for osteoporosis studies

  2024cites this paper
• Osteoporose – Definition, Risikoerfassung, Diagnose, Prävention und Therapie (Update 2024)

  2024cites this paper
• Medication-Related Osteonecrosis of the Jaw: Bibliometric Analysis from 2003 to 2023.

  2024cites this paper
• Bone Targeting Nanoparticles for the Treatment of Osteoporosis

  2024cites this paper
• Impact of Bisphosphonate Therapy on Oral Health in Patients with Breast and Prostate Cancer and Bone Metastases: A Comprehensive Study

  2024cites this paper
• Pathophysiology of Medication‐Related Osteonecrosis of the Jaw—A Minireview

  2023cites this paper
• Dentists’ Awareness of Medication-Related Osteonecrosis of the Jaw (Risk Factors, Drugs, and Prevention) in the Republic of Croatia

  2023cites this paper
• Methoxyflavones isolated from the whole plant of Scutellaria rubropunctata Hayata var. rubropunctata promote osteoblast differentiation in MC3T3-E1 cells

  2023cites this paper
• Einfluss von Zoledronat und Denosumab auf humane Zellen der osteoblastären Linie aus dem Kieferknochen anhand osteogener Marker

  2023influential citation
• Management of Medication-Related Osteonecrosis of the Jaw with Photobiomodulation and Minimal Surgical Intervention

  2023cites this paper
• Drug-induced osteopetrosis.

  2023cites this paper
• Romosozumab-associated medication-related osteonecrosis of the jaw

  2023cites this paper
• Prevalence of Precursory Signs of Atypical Femoral Fractures in Patients Receiving Bone‐Modifying Agents for Bone Metastases: A Cross‐Sectional Study

  2023cites this paper
• Surgical Treatment in Patients with Toxic Phosphorus Osteonecrosis of Facial Skull Middle Zone

  2023cites this paper
• Clinical significance of drug cessation on medication-related osteonecrosis of the jaw in patients with osteoporosis

  2023cites this paper
• Bisphosphonate and its impact on orthodontic tooth movement

  2023cites this paper
• Spontaneous Osteogenic Potential of Periosteum after Segmental Mandibulectomy in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ): A Retrospective Study of 14 Cases

  2023cites this paper
• Self Regeneration of a Comprehensive Bony Defect and Mandibular Nerve Following Mandibular Resection Mandibular Rezeksiyon Sonras ı Geni ş Kemik Defektinin ve Mandibular Sinirin Rejenerasyonu

  2023cites this paper
• Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in Taiwan

  2023influential citation
• Cooperation between physicians and dentists for osteonecrosis of the jaw: a 2022 Japanese survey

  2023cites this paper
• Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents - A retrospective study of 240 patients.

  2023cites this paper
• Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from 2016 to 2020 in Kure, Japan

  2023cites this paper
• Faktor-faktor yang Mempengaruhi PenurunanTulang Marginal Pada Awal Pemasangan Implan Dental

  2023cites this paper
• Biomimetic Collagen Membranes as Drug Carriers of Geranylgeraniol to Counteract the Effect of Zoledronate

  2023cites this paper
• Evaluation of cortical and trabecular bone structure of the mandible in patients using L-Thyroxine

  2023cites this paper
• Role of Actinomyces spp. and related organisms in the development of medication-related osteonecrosis of the jaw (MRONJ): Clinical evidence based on a case series

  2023cites this paper
• Reliability of early stage symptoms/clinical findings of osteonecrosis of the jaw: Japanese Osteoporosis Intervention Trial-05 (JOINT-05)

  2023cites this paper
• Diagnosis and Management of Pathological Conditions.

  2023cites this paper
• Clinical impact on dental implant survival in patients taking antiresorptive medications: A systematic review and meta-analysis.

  2023cites this paper
• Awareness of medical doctor on medication-related osteonecrosis of the jaw in osteoporosis patients

  2023cites this paper
• Determining patient preferences for the medical management of osteoporosis using conjoint analysis

  2023cites this paper
• Is maxillary sinusitis and radiographic maxillary sinus opacification associated with an altered microbiology of MRONJ?

  2023cites this paper
• Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ

  2023cites this paper
• Fatores de risco para osteonecrose dos maxilares relacionada à medicação e níveis salivares de IL‐6 em pacientes com câncer

  2022cites this paper
• Reporting Criteria for Clinical Trials on Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review and Recommendations

  2022cites this paper
• Advancement in the Treatment of Osteoporosis and the Effects on Bone Healing

  2022cites this paper
• Efficacy of Adjunctive Photobiomodulation in the Management of Medication-Related Osteonecrosis of the Jaw: A Systematic Review

  2022cites this paper
• Comparison of simvastatin 1.2% gel and alendronate 1% gel in chronic periodontitis as local drug delivery: A randomized clinical trial

  2022cites this paper
• Refinements in the reconstruction of bisphosphonate-related osteonecrosis of the jaw

  2022cites this paper
• Laser Therapy for Adjunctive Treatment of Peri-implant Disease

  2022cites this paper
• Alternativas terapéuticas de osteonecrosis maxilar asociada a medicamentos (ONMAM) reportes de dos casos clínicos y revisión de la literatura

  2022cites this paper
• Effects of Ultraviolet Treatment and Alendronate Immersion on Osseointegration of Dental Implants and Mucosal Attachment of Dental Implant Abutments.

  2022cites this paper
• Antimicrobian Photodynamic Therapy in Medication-Related Osteonecrosis of the Jaws.

  2022cites this paper